The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. Shafritz KM, Marchione KE, Gore JC, Shaywitz SE, Shaywitz BA (2004) Am J Psychiatry 161: 1990-7 Serotonin transporter inhibition and 5-HT receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice. Stewart A, Davis GL, Gresch PJ, Katamish RM, Peart R, Rabil MJ, Gowrishankar R, Carroll FI, Hahn MK, Blakely RD (2019) Neuropsychopharmacology 44: 994-1006 Anomalous dopamine release associated with a human dopamine transporter coding variant. Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, Blakely RD (2008) J Neurosci 28: 7040-6 Contrasting actions of pressor agents in severe autonomic failure. Jordan J, Shannon JR, Biaggioni I, Norman R, Black BK, Robertson D (1998) Am J Med 105: 116-24 Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Carlezon WA, Konradi C (2004) Neuropharmacology 47 Suppl 1: 47-60 Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration. Barnett JV, Kuczenski R (1986) J Pharmacol Exp Ther 237: 820-5 Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. Mergy MA, Gowrishankar R, Davis GL, Jessen TN, Wright J, Stanwood GD, Hahn MK, Blakely RD (2014) Neurochem Int 73: 56-70
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.